Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Current Opinion in Nephrology and Hypertension|March 6, 2020
The glomerular crescent: triggers, evolution, resolution, and implications for therapyLidia Anguiano, Renate Kain, Hans-Joachim AndersJournal of Clinical Medicine|August 5, 2015
Endothelin Blockade in Diabetic Kidney DiseaseLidia Anguiano, Marta Riera, Julio Pascual, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 10, 2017
The diabetes pandemic suggests unmet needs for 'CKD with diabetes' in addition to 'diabetic nephropathy'-implications for pre-clinical research and drug testingLidia Anguiano Gómez, Yutian Lei, Satish Kumar Devarapu, et al.American Journal of Physiology. Renal Physiology|December 25, 2015
Paricalcitol modulates ACE2 shedding and renal ADAM17 in NOD mice beyond proteinuriaMarta Riera, Lidia Anguiano, Sergi Clotet, et al.Laboratory Investigation; a Journal of Technical Methods and Pathology|June 10, 2018
Sex dimorphism in ANGII-mediated crosstalk between ACE2 and ACE in diabetic nephropathySergi Clotet-Freixas, Maria Jose Soler, Vanesa Palau, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 28, 2015
Circulating angiotensin-converting enzyme 2 activity in patients with chronic kidney disease without previous history of cardiovascular diseaseLidia Anguiano, Marta Riera, Julio Pascual, et al.Scientific Reports|November 16, 2017
Phagocytosis of environmental or metabolic crystalline particles induces cytotoxicity by triggering necroptosis across a broad range of particle size and shapeMohsen Honarpisheh, Orestes Foresto-Neto, Jyaysi Desai, et al.Atherosclerosis|September 13, 2016
Circulating angiotensin converting enzyme 2 activity as a biomarker of silent atherosclerosis in patients with chronic kidney diseaseLidia Anguiano, Marta Riera, Julio Pascual, et al.Frontiers in Immunology|October 16, 2018
The Long Pentraxin PTX3 Is an Endogenous Inhibitor of Hyperoxaluria-Related Nephrocalcinosis and Chronic Kidney DiseaseJulian A Marschner, Shrikant R Mulay, Stefanie Steiger, et al.International Journal of Cardiology|October 14, 2018
ACE2 and ACE in acute and chronic rejection after human heart transplantationMaria Jose Soler, Montserrat Batlle, Marta Riera, et al.Pageof 2